Recombinant Human Fibrinogen gamma chain Protein
Beta LifeScience
SKU/CAT #: BLPSN-2089

Recombinant Human Fibrinogen gamma chain Protein
Beta LifeScience
SKU/CAT #: BLPSN-2089
Catalog No.: BLPSN-2089
Product Overview
Tag | N/A |
Host Species | Human |
Accession | NP_068656.2 |
Background | Loss of function mutations in FGG have been associated with fibrinogen deficiency. FGG mRNA was expressed abnormally in HCC and elevated plasma fibrinogen may serve as a useful predictor of clinical progression of HCC patients. |
Description | A DNA sequence encoding the human FGG (NP_068656.2) (Val169-Leu453) was expressed. |
Source | Yeast |
Predicted N Terminal | Val 169 |
AA Sequence | Val169-Leu453 |
Molecular Weight | The recombinant human FGG consists of 285 a.a. and predicts a molecular mass of 32.2 kDa. |
Purity | >95% as determined by SDS-PAGE. |
Endotoxin | Please contact us for more information. |
Bioactivity | Please contact us for detailed information |
Formulation | Lyophilized from sterile PBS, pH 7.4.. |
Stability | The recombinant proteins are stable for up to 1 year from date of receipt at -70°C. |
Usage | For Research Use Only |
Storage | Store the protein under sterile conditions at -20°C to -80°C. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles. |